Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-11-14 4:28 pm Unchanged | 13G | SUNSHINE BIOPHARMA INC WT EXP SBFMW | ARMISTICE CAPITAL LLC | 0 0.000% | 0 (Unchanged) | View |
| 2024-02-23 4:03 pm Purchase | 13G | SUNSHINE BIOPHARMA INC WT EXP SBFMW | L1 Capital Global Opportunities Master Fund Ltd. | 5,285,714 5.300% | 5,285,714 (New Position) | View |
| 2024-02-21 4:28 pm Purchase | 13G | SUNSHINE BIOPHARMA INC WT EXP SBFMW | Altium Capital Management LP | 9,000,000 9.990% | 9,000,000 (New Position) | View |
| 2024-02-14 3:53 pm Purchase | 13G | SUNSHINE BIOPHARMA INC WT EXP SBFMW | ARMISTICE CAPITAL LLC | 2,130,000 7.600% | 2,130,000 (New Position) | View |
| 2022-11-02 11:13 am Purchase | 13G | SUNSHINE BIOPHARMA INC WT EXP SBFMW | Chamoun Malek | 3,700,000 16.400% | 3,700,000 (New Position) | View |
| 2021-07-29 4:45 pm Purchase | 13G | SUNSHINE BIOPHARMA INC WT EXP SBFMW | Beathard Robert King 3rd | 39,231,743 8.070% | 39,231,743 (New Position) | View |